New Clinical Data Support the Utility of Epi proColon® Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome

    NEXT STORY
    Spero Therapeutics to Present Data for All Pipeline Programs at the ASM Microbe 2019 Conference
    PREV STORY
    Arbutus Appoints William Collier as Next President & CEO and Announces Retirement of Current President & CEO, Mark J. Murray Ph.D.
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer

    author_avatar
    NASDAQ Market News

    Aptose to Participate in Upcoming Investor Conferences

    SAN DIEGO and TORONTO, March 02, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) ...

    author_avatar
    NASDAQ Market News

    NewLink Genetics Corporation Top Infectious Disease Scientist to Present at Special Zika Conference Called by American Society for Microbiology

    AMES, Iowa, June 01, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced ...

    author_avatar
    NASDAQ Market News